Developing life-changing gene therapies for fatal and debilitating diseases of the central nervous system

Voyager Therapeutics is a clinical stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS). Gene therapy has the potential to transform the treatment of CNS and other diseases by providing a one-time therapy that dramatically improves patients' lives. We are committed to advancing the field of adeno-associated virus (AAV) gene therapy through innovation and investment in vector optimization and engineering, dosing techniques, as well as process development and production.

APRIL 21, 2016

Voyager Therapeutics Among Boston Business Journal's 2016 Best Places to Work

Read the Story

May 12, 2016

Voyager Therapeutics Provides First Quarter 2016 Investor Update